These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26954467)

  • 1. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.
    Ng OW; Chia A; Tan AT; Jadi RS; Leong HN; Bertoletti A; Tan YJ
    Vaccine; 2016 Apr; 34(17):2008-14. PubMed ID: 26954467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide B Cell, CD4
    Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
    J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
    Liu J; Sun Y; Qi J; Chu F; Wu H; Gao F; Li T; Yan J; Gao GF
    J Infect Dis; 2010 Oct; 202(8):1171-80. PubMed ID: 20831383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.
    Peng H; Yang LT; Wang LY; Li J; Huang J; Lu ZQ; Koup RA; Bailer RT; Wu CY
    Virology; 2006 Aug; 351(2):466-75. PubMed ID: 16690096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.
    Zhao J; Zhao J; Mangalam AK; Channappanavar R; Fett C; Meyerholz DK; Agnihothram S; Baric RS; David CS; Perlman S
    Immunity; 2016 Jun; 44(6):1379-91. PubMed ID: 27287409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
    Veit S; Jany S; Fux R; Sutter G; Volz A
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.
    Yang L; Peng H; Zhu Z; Li G; Huang Z; Zhao Z; Koup RA; Bailer RT; Wu C
    J Gen Virol; 2007 Oct; 88(Pt 10):2740-2748. PubMed ID: 17872527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
    Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
    Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.
    Chen H; Hou J; Jiang X; Ma S; Meng M; Wang B; Zhang M; Zhang M; Tang X; Zhang F; Wan T; Li N; Yu Y; Hu H; Yang R; He W; Wang X; Cao X
    J Immunol; 2005 Jul; 175(1):591-8. PubMed ID: 15972696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Chan C; He Y; Jiang S; Wu C; Jin DY; Yuen KY; Zhou Y; Zheng BJ
    Vaccine; 2008 Mar; 26(13):1644-51. PubMed ID: 18289745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope.
    Cheung YK; Cheng SC; Sin FW; Chan KT; Xie Y
    Vaccine; 2007 Aug; 25(32):6070-7. PubMed ID: 17629360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
    Kim TW; Lee JH; Hung CF; Peng S; Roden R; Wang MC; Viscidi R; Tsai YC; He L; Chen PJ; Boyd DA; Wu TC
    J Virol; 2004 May; 78(9):4638-45. PubMed ID: 15078946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.
    Zhao K; Yang B; Xu Y; Wu C
    Vaccine; 2010 Sep; 28(41):6666-74. PubMed ID: 20709007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.
    Oh HL; Chia A; Chang CX; Leong HN; Ling KL; Grotenbreg GM; Gehring AJ; Tan YJ; Bertoletti A
    J Virol; 2011 Oct; 85(20):10464-71. PubMed ID: 21813600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-mediated immune response to respiratory coronaviruses.
    Channappanavar R; Zhao J; Perlman S
    Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.